A Pilot Study of Romidepsin in Relapsed or Refractory Extranodal NK/T-cell Lymphoma

Clinical trial NCT01913119 · COMPLETED

Trial details

NCT number: NCT01913119
Sponsor: Samsung Medical Center
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Histologically Proven Extranodal NKTcell Lymphoma

Start date: 2013-07-01
Primary completion: 2013-07-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.